Thinly traded nano cap PolarityTE (NASDAQ:PTE) is up 8% premarket on light volume in reaction to positive results
from an open-label single-arm pilot study evaluating SkinTE for closing
venous stasis leg ulcers (VLUs) that have not responded to convention
treatments. The data were presented at the Symposium on Advanced Wound
Care Fall Meeting in Las Vegas.
10 patients with VLUs that remained open after at
least one month of conventional treatments participated. After receiving
SkinTE, an autologous, homologous human cellular and tissue-based
product, 80% of the VLUs closed within 12 weeks. 100% of the VLUs showed
graft take and initial signs of closure.
A 100-subject Phase 1 trial is in process with an estimated completion date in September 2020.
https://seekingalpha.com/news/3505477-polarityte-8-percent-premarket-positive-skinte-data
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.